I-027

Interference Mix 5

100 μg/mL in methanol (each analyte), Cerilliant^®

• Synonym(s): Qualitative Interference Mixture
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• grade: analytical standard
• form: liquid
• composition: Carbamazepine, 100 μg/mL ; Levetiracetam, 100 μg/mL ; Metformin hydrochloride, 100 μg/mL (as free base); Phenobarbital, 100 μg/mL ; R(-)-Phenylephrine hydrochloride, 100 μg/mL (as free base); Phenytoin, 100 μg/mL ; Sertraline hydrochloride, 100 μg/mL (as free base); Topiramate, 100 μg/mL ; Zolpidem tartrate, 100 μg/mL ; Zonisamide, 100 μg/mL
• packaging: ampule of 1 mL
• manufacturer/tradename: Cerilliant^®
• drug control: psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• concentration: 100 μg/mL in methanol (each analyte)
• technique(s): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• application(s): forensics and toxicology
• format: single component solution
• storage temp.: −20°C

Description

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs carbamazepine, metformin, sertraline, zonisamide, levetiracetam, phenobarbital, topiramate, phenytoin, zolpidem and (R)-phenylephrine. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Safety Information

• pictograms: GHS02,GHS06,GHS08,GHS09
• signalword: Danger
• hcodes: H225,H301 + H311 + H331,H370,H411
• pcodes: P210 - P273 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 2 - Flam. Liq. 2 - STOT SE 1
• target_organs: Eyes,Central nervous system
• Storage Class: 3 - Flammable liquids
• wgk_germany: WGK 3
• flash_point_f: 49.5 °F - closed cup
• flash_point_c: 9.7 °C - closed cup